Loss of conserved long non-coding RNA MIR503HG leads to altered NOTCH pathway signalling and left ventricular non-compaction cardiomyopathy
Cardiovascular Research · 2025
DOI: 10.1093/cvr/cvaf043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von João P Monteiro und 24 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Myocytes, Cardiac, MicroRNAs, Ventricular Function, Left. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, National Heart Foundation of Australia, Australian Research Council.
Abstract (Originalsprache)
Aims
The highly conserved long non-coding RNA (lncRNA) MIR505HG has been primarily recognized as a precursor for microRNAs (miR)-424 and miR-503. However, studies have since demonstrated that MIR503HG has distinct functions from its associated miRNAs, playing important roles in cell proliferation, invasion, apoptosis, and differentiation. While these miRNAs are known to influence cardiomyocyte differentiation, the specific role of MIR503HG in heart development remains unexplored. We seek to determine how MIR503HG deletion impacts ventricular chamber development and to identify underlying molecular mechanisms. Methods and results To study the role of the lncRNA in vivo, we generated a functional MIR503HG knockout mouse model (MIR503HG−/−) using a synthetic polyadenylation signal to terminate MIR503HG transcription without affecting miR-424/503 expression. We performed morphological analyses on embryonic and adult hearts using microCT along with cardiac functional analysis via transthoracic echocardiography. We further apply single-nuclei RNA sequencing (snRNA-seq) on adult hearts to identify potential molecular mechanisms underlying the observed phenotypes. Functional deletion of MIR503HG alone was associated with reduced compact myocardium thickness and increased trabecular myocardium in the left ventricle (LV) at embryonic day 17.5 compared to wild-type mice, indicating a LV non-compaction (LVNC) phenotype. Moreover, adult MIR503HG−/− mutant hearts showed increased trabecular complexity, impaired LV relaxation, and mitral valve regurgitation. SnRNA-seq further revealed altered expression of several genes associated with cardiomyocyte function and LVNC, including Actc1, Mib1, Mybpc3, and Myh7. Lastly, Notch1 activity was also significantly increased in mutant hearts which has been previously associated with LVNC.
Conclusion
MIR503HG plays a role in ventricular chamber development, and its deletion leads to an LVNC phenotype independent of the miRNA cluster within its locus, highlighting its importance in cardiac development and disease. We further suggest that abnormal Notch1 activity may underpin the LVNC phenotype presented.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.
- Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Australian Regenerative Medicine Institute, 15 Innovation Walk, Monash University, Clayton, VIC 3800, Australia.
- Victor Chang Cardiac Research Institute, Darlinghurst, NSW 2010, Australia.
- School of Clinical Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
- Centre for Regenerative Medicine, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh EH16 4UU, UK.
ORCID-Profile: João P Monteiro, Ana-Mishel Spiroski, Peter Kaltzis, Vaibhao Janbandhu, Francesco Severi, Azzurra Laura De Pace, Julie Rodor, Abdelaziz Beqqali, Kevin Stewart, Adrian Thomson, Patrick W F Hadoke, Dyana Markose, John R Wilson-Kanamori, Neil C Henderson, Thomas Quertermous, Richard P Harvey, Gonzalo Del Monte-Nieto, Andrew H Baker
Förderung
- British Heart Foundation
- National Heart Foundation of Australia
- Australian Research Council
- National Health and Medical Research Council
- BHF/DHF/DZHK
- Heart Foundation of Australia Future Leader Fellowship
Zitieren
APA
Monteiro, J. P., Saha, D., Spiroski, A. M., Mahesh, S., Kaltzis, P., Nadavallil, A., Janbandhu, V., Murray, N. J., Severi, F., De Pace, A. L., Sánchez-Esteban, S., Rodor, J., Beqqali, A., Bennett, M., Stewart, K., Thomson, A., Hadoke, P. W. F., Markose, D., Wilson-Kanamori, J. R., …, & Baker, A. H. (2025). Loss of conserved long non-coding RNA MIR503HG leads to altered NOTCH pathway signalling and left ventricular non-compaction cardiomyopathy. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf043
Vancouver
Monteiro JP, Saha D, Spiroski AM, Mahesh S, Kaltzis P, Nadavallil A, et al. Loss of conserved long non-coding RNA MIR503HG leads to altered NOTCH pathway signalling and left ventricular non-compaction cardiomyopathy. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf043
BibTeX
@article{Monteiro2025,
author = {Monteiro, João P and Saha, Diptarka and Spiroski, Ana-Mishel and Mahesh, Saiba and Kaltzis, Peter and Nadavallil, Abhijit and Janbandhu, Vaibhao and Murray, Nicholas J and Severi, Francesco and De Pace, Azzurra Laura and Sánchez-Esteban, Sandra and Rodor, Julie and Beqqali, Abdelaziz and Bennett, Matthew and Stewart, Kevin and Thomson, Adrian and Hadoke, Patrick W F and Markose, Dyana and Wilson-Kanamori, John R and Henderson, Neil C and O'Carroll, Dónal and Quertermous, Thomas and Harvey, Richard P and Del Monte-Nieto, Gonzalo and Baker, Andrew H},
title = {Loss of conserved long non-coding RNA MIR503HG leads to altered NOTCH pathway signalling and left ventricular non-compaction cardiomyopathy},
journal = {Cardiovascular Research},
year = {2025},
doi = {10.1093/cvr/cvaf043}
}
EUVIMED